Two different studies suggested that tumours with loss of function of VHL were more likely to be sensitive to anti-VEGF drugs, thus suggesting that both VHL and VEGF status are potentially important for predicting response to TKIs (Rini et al, 2006; Choueiri et al, 2008b). This evidence concerns the gene VEGFA and neoplasm.